Primary |
Pain |
42.8% |
Product Used For Unknown Indication |
23.9% |
Back Pain |
10.7% |
Breakthrough Pain |
4.1% |
Arthralgia |
1.6% |
Back Disorder |
1.6% |
Drug Diversion |
1.6% |
Intervertebral Disc Degeneration |
1.6% |
Intervertebral Disc Protrusion |
1.6% |
Pain In Extremity |
1.6% |
Drug Abuse |
1.2% |
Arthritis |
0.8% |
Biliary Cirrhosis |
0.8% |
Compression Fracture |
0.8% |
Depression |
0.8% |
Femoroacetabular Impingement |
0.8% |
Fibromyalgia |
0.8% |
Gastric Ulcer |
0.8% |
Gastrooesophageal Reflux Disease |
0.8% |
Hepatic Cirrhosis |
0.8% |
|
Medication Residue Present |
32.2% |
Withdrawal Syndrome |
7.8% |
Drug Diversion |
6.7% |
Vomiting |
6.7% |
Tremor |
5.6% |
Drug Effect Decreased |
4.4% |
Drug Screen Negative |
3.3% |
Muscle Spasms |
3.3% |
Nausea |
3.3% |
No Adverse Event |
3.3% |
Wrong Technique In Drug Usage Process |
3.3% |
Drug Screen Positive |
2.2% |
Feeling Abnormal |
2.2% |
Malaise |
2.2% |
Migraine |
2.2% |
Pyrexia |
2.2% |
Regurgitation |
2.2% |
Skin Fissures |
2.2% |
Swelling Face |
2.2% |
Urinary Retention |
2.2% |
|
Secondary |
Pain |
19.9% |
Arthritis |
6.8% |
Back Disorder |
6.8% |
Compression Fracture |
6.8% |
Femoroacetabular Impingement |
6.8% |
Fibromyalgia |
6.8% |
Sleep Apnoea Syndrome |
6.8% |
Systemic Lupus Erythematosus |
6.8% |
Back Pain |
4.5% |
Intervertebral Disc Protrusion |
4.5% |
Biliary Cirrhosis |
3.4% |
Gastric Ulcer |
3.4% |
Hepatic Cirrhosis |
3.4% |
Nerve Injury |
3.4% |
Pain In Extremity |
2.3% |
Arthralgia |
1.7% |
Intervertebral Disc Degeneration |
1.7% |
Product Used For Unknown Indication |
1.7% |
Back Injury |
1.1% |
Depression |
1.1% |
|
Medication Residue Present |
21.9% |
Musculoskeletal Pain |
9.4% |
Urinary Straining |
9.4% |
Pruritus Generalised |
6.3% |
Skin Fissures |
6.3% |
Withdrawal Syndrome |
6.3% |
Bronchospasm |
3.1% |
Drug Abuse |
3.1% |
Drug Effect Increased |
3.1% |
Drug Screen Negative |
3.1% |
Feeling Abnormal |
3.1% |
Intentional Drug Misuse |
3.1% |
No Adverse Event |
3.1% |
Pancreatitis |
3.1% |
Regurgitation |
3.1% |
Renal Cyst Infection |
3.1% |
Speech Disorder |
3.1% |
Tremor |
3.1% |
Vomiting |
3.1% |
|
Concomitant |
Pain |
32.5% |
Back Pain |
12.0% |
Product Used For Unknown Indication |
9.4% |
Back Disorder |
6.8% |
Biliary Cirrhosis |
6.8% |
Gastric Ulcer |
6.8% |
Hepatic Cirrhosis |
6.8% |
Breakthrough Pain |
5.1% |
Neuropathy Peripheral |
3.4% |
Pain In Extremity |
3.4% |
Gastrooesophageal Reflux Disease |
1.7% |
Intervertebral Disc Degeneration |
1.7% |
Spinal Cord Injury |
1.7% |
Cancer Pain |
0.9% |
Chronic Myeloid Leukaemia |
0.9% |
|
Medication Residue Present |
17.6% |
Urinary Straining |
11.8% |
Wrong Technique In Drug Usage Process |
11.8% |
Drug Effect Decreased |
5.9% |
Drug Ineffective |
5.9% |
Withdrawal Syndrome |
5.9% |
Arthropathy |
2.9% |
Bronchospasm |
2.9% |
Flatulence |
2.9% |
Hyperhidrosis |
2.9% |
Hypersensitivity |
2.9% |
Inappropriate Schedule Of Drug Administration |
2.9% |
Inhibitory Drug Interaction |
2.9% |
Intestinal Obstruction |
2.9% |
Malaise |
2.9% |
No Adverse Event |
2.9% |
Oral Discomfort |
2.9% |
Pruritus |
2.9% |
Regurgitation |
2.9% |
Skin Haemorrhage |
2.9% |
|